We provide 1 form of Dabrafenib
Dabrafenib
1195765-45-7
|
519.101
|
4.61
Dabrafenib is an orally bioavailable inhibitor of B-raf protein with antineoplastic activity. It is used to treat patients with specific types of melanoma, non-small cell lung cancer, and thyroid cancer.
GSK2118436 | GSK2118436A | dabrafenib | tafinlar
Dabrafenib is an orally bioavailable inhibitor of B-raf protein with antineoplastic activity. It is used to treat patients with specific types of melanoma, non-small cell lung cancer, and thyroid cancer.
GSK2118436 | GSK2118436A | dabrafenib | tafinlar
$48/5 mg
(EBC)
1
We provide 0 compound for Dabrafenib